Enter your Email address:

Wolters Kluwer Health may email you for journal alerts and information, but is committed to maintaining your privacy and will not share your personal information without your express consent. For more information, please refer to our Privacy Policy.

Anti-Cancer Drugs

Wolters Kluwer Health Logo

Search Jobs

Login
Register
Activate Subscription
Subscribe
eTOC
Help

Advanced Search
Saved Searches
Recent Searches

You currently have no recent searches

Home	Current Issue	Previous Issues	Published Ahead-of-Print	For Authors	Journal Info

Information for Authors

Language Editing Services

About the Journal

Editorial Board

Advertising

Subscription Services

Reprints

Rights and Permissions

Mobile

New Features

Editor-in-Chief:	Mels Sluyser, PhD
ISSN:	0959-4973
Online ISSN:	1473-5741
Frequency:	10 / year
Ranking:	107 of 194 Oncology, 116 of 261 Pharmacology & Pharmacy
Impact Factor:	2.407

Current Issue: June 2013 - Volume 24 - Issue 5

Subscribe to eTOC

Add Item(s) to:

An Existing Folder

A New Folder

Folder Name:

Description:

The item(s) has been successfully added to "".

Email to a Colleague

Colleague's E-mail is Invalid

Your Name: (optional)

Your Email:

Colleague's Email:

Separate multiple e-mails with a (;).

Message:
Thought you might appreciate this item(s) I saw at Anti-Cancer Drugs.

Send a copy to your email

Your message has been successfully sent to your colleague.

Some error has occurred while processing your request. Please try after some time.

Export to.

End Note
Procite
Reference Manager

Save my selection

Current Issue Highlights

Actions

Add to My Favorites
Email to Colleague
Export to Citation Manager

View

Title
Citation
Abstract

Review Article

Bisphosphonates and vascular endothelial growth factor-targeted drugs in the treatment of patients with renal cell carcinoma metastatic to bone

Vrdoljak, Eduard; Rini, Brian; Schmidinger, Manuela; Omrcen, Tomislav; Torday, Laszlo; Szczylik, Cezary; Sella, Avishay

Anti-Cancer Drugs. 24(5):431-440, June 2013.

doi: 10.1097/CAD.0b013e328360335f

Purchase Access

+ Favorites

EPUB EPUB

PDF (568 KB)

Abstract

Abstract:

Preclinical Reports

Bipiperidinyl derivatives of 23-hydroxybetulinic acid reverse resistance of HepG2/ADM and MCF-7/ADR cells

Zhang, Dong-Mei; Li, Ying-Jie; Shu, Chang; Ruan, Zhi-Xiong; Chen, Wei-Min; Yiu, Anita; Peng, Ying-Hui; Wang, Jiao; Lan, Ping; Yao, Zhe; Fung, Kwok-Pui; Fu, Li-Wu; Chen, Zhe-Sheng; Ye, Wen-Cai

Anti-Cancer Drugs. 24(5):441-454, June 2013.

doi: 10.1097/CAD.0b013e32835fcc77

Purchase Access

+ Favorites

EPUB EPUB

PDF (1.17 MB)

Abstract

Abstract:

Clinical Report

Continuous treatment with new agents for newly diagnosed multiple myeloma

Zou, Yandun; Sheng, Zhixin; Lu, Hongkai; Yu, Jinming

Anti-Cancer Drugs. 24(5):527-533, June 2013.

doi: 10.1097/CAD.0b013e32836032d5

Purchase Access

+ Favorites

EPUB EPUB

PDF (438 KB)

Abstract

Abstract:

Table of Contents Sections

Review Article
Preclinical Reports
Clinical Report

Actions

Add to My Favorites
Email to Colleague
Export to Citation Manager

View

Title
Citation
Abstract

Username or Email:

Password:

Remember me

Forgot Password?

Need to Activate a New Subscription?
Recently purchased a subscription? Login or Register a new account and enter your subscription ID, or Subscribe Now!

Forgot your Password?

Enter and submit the email address you registered with. An email with instructions to reset your password will be sent to that address.

Email:

Password Sent

Link to reset your password has been sent to specified email address.

Remember me

What does "Remember me" mean?
By checking this box, you'll stay logged in for 14 days or until you logout. You'll get easier access to your articles, collections, media, and all your other content, even if you close your browser or shut down your computer.

To protect your most sensitive data and activities (like changing your password), we'll ask you to re-enter your password when you access these services.

What if I'm on a computer that I share with others?
If you're using a public computer or you share this computer with others, we recommend that you uncheck the "Remember me" box.